Earnings call Transcript for the quarter and year ended March 31, 2026

Krsnaa Diagnostics reported FY '26 revenue of INR 7,728 million with EBITDA of INR 2,149 million (28% margin) and PAT of INR 1,014 million, growing 101% YoY in Q4. The company crossed INR 1,000 million PAT for the first time. Rajasthan PPP project, which involved deploying 27 mother labs and 800+ collection centers, saw no revenue contribution in FY '26 but is expected to contribute INR 100-150 crores from Q1 FY '27. Retail business scaled 6x to INR 60 crores, contributing 8% of revenues. Collections improved with DSO reducing from 155 days to 139 days, targeting sub-120 days in FY '27. The company plans INR 5,000 million capex in FY '27 combining Rajasthan (INR 300 crores) and MRI expansion (INR 150 crores). Long-term revenue visibility stands at INR 6,000-7,000 crores over 5-7 years.